INTRAVESICAL THIOTEPA IN THE TREATMENT OF TRANSITIONAL CELL BLADDER CARCINOMA
- 4 December 2008
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 43 (2) , 185-188
- https://doi.org/10.1111/j.1464-410x.1971.tb12024.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Thiotepa Bladder Instillations: Therapy and Prophylaxis for Superficial Bladder TumorsJournal of Urology, 1969
- The Role of Thiotepa Instillations in Bladder CancerPublished by American Medical Association (AMA) ,1968
- The Effects of Topical Thiotepa on the Recurrence Rate of Superficial Bladder CancersJournal of Urology, 1968
- Severe Pancytopenia Associated with the use of Intravesical Thio-TepaJournal of Urology, 1967
- Pancytopenia and Generalized Sepsis Following Treatment of cancer of the Bladder with Instillations of triethylene ThiophosphoramideJournal of Urology, 1967
- The Prophylactic Use of Thio-Tepa in Transitional Cell Carcinoma of the BladderJournal of Urology, 1966
- Intracavitary Chemotherapy of Diffuse Non-Infiltrating Papillary Carcinoma of the BladderJournal of Urology, 1966
- Bladder Carcinoma Treated by Direct Instillation of Thio-TepaJournal of Urology, 1962
- THIOTEPA IN THE TREATMENT OF TUMOURS OF THE BLADDERThe Lancet, 1961
- Further Studies on Absorption Through the Human BladderJournal of Urology, 1955